Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

GLP-1 AND C-PEPTIDE ARE ASSOCIATED WITH INSULIN RESISTANCE AMONG PLWH IN INDIA

By Enthusiast Inc MDMarch 6, 2018

Incretins (Glucagon like peptide-1 [GLP-1] and glucose-dependent insulinotropic peptide [GIP]) regulate glucose homeostasis in HIV-uninfected individuals. Inflammation has been implicated as a cause for insulin resistance (IR) among PLWH. Little…

Effects of Three Regimens of PEP on the Immune System of HIV-Seronegative Individuals

By Enthusiast Inc MDFebruary 27, 2015

…(MNC) from rectal biopsy specimens were collected from 30 men who have sex with men (MSM) with a potential sexual exposure. All of them were selected from two different PEP…

1040 – Real-World Clinical Outcomes of Doxycycline Postexposure Prophylaxis for Bacterial STI Prevention

By Jimmy He PharmD, DScMarch 31, 2026

Background Doxycycline post-exposure prophylaxis (DoxyPEP) prevents bacterial STIs in trials, but real-world effectiveness and safety signals remain uncertain. Methods We reviewed people presenting to a community sexual health clinic in…

Final Results of ANRS 174 DOXYVAC: A Randomized Trial to Prevent STI in MSM on PrEP

By Jimmy He PharmD, DScApril 26, 2024

…MSM were randomized and 545 were analyzed. Median age: 40 years (IQR 34-48), median of 10 sexual partners in past 3 months. Median follow-up: 14 months. There was no interaction…

1085 – PEPFAR-Supported Sites in Sub-Saharan Africa Exposed to Conflict in 2024

By Jimmy He PharmD, DScApril 1, 2026

…disruptions and ensure treatment access and outcomes. Methods We sourced 2024 conflict data from the Armed Conflict Location and Event Data Project (ACLED) for 24 sub-Saharan African countries. We extracted…

DoxyPEP: Should We Worry About Antimicrobial Resistance?

By Jimmy He PharmD, DScApril 26, 2024

Presentation: Increased rates of bacterial sexually transmitted infections (STIs) are reported among men who have sex with men (MSM), particularly among those using HIV pre-exposure prophylaxis (PrEP). Interventions to reduce…

RATIONALLY DESIGNED ACE2-DERIVED PEPTIDES INHIBIT SARS-CoV-2

By Jimmy He PharmD, DScApril 22, 2021

…that inhibited infection with genuine SARS-CoV-2. Our work demonstrates the feasibility of inhibiting SARS-CoV-2 with peptide-based inhibitors. These findings will allow for the successful development of engineered peptides and peptidomimetic-based…

CHARACTERISTICS OF DEATHS IN A PEPFAR HIV PROGRAM IN DEMOCRATIC REPUBLIC OF THE CONGO

By Jimmy He PharmD, DScApril 4, 2022

…of PLHIV in DRC. We aimed to evaluate the proportion and characteristics of PLHIV who were lost from treatment and died in DRC PEPFAR programs. We conducted an analysis using…

1036 – Doxycycline Postexposure Prophylaxis Impact on Neisseria gonorrhoeae Antimicrobial Susceptibility

By Jimmy He PharmD, DScMarch 31, 2026

…visits. Logistic regression with Generalized Estimating Equations (GEE), to account for repeated measures, was used to assess the associations between DoxyPEP use and HR/R/DS rates. GEE model with log-transformed MICs…

PEP-IN-POCKET (PIP): LONG-TERM FOLLOW-UP OF ON DEMAND HIV POST-EXPOSURE PROPHYLAXIS

By Jimmy He PharmD, DScMarch 3, 2023

…with 28 days of PEP medication before an exposure occurs, along with instructions on when to initiate medications and how to follow up with care. We present long-term follow-up of…

←1
234567
…89101112…
13141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top